|
ChemGenex Pharmaceuticals Limited (ASX: CXS, Nasdaq: CXSP), based in
Melbourne, Australia and Menlo Park, California, U.S.A., and Stragen Pharma
S.A., based in Geneva, Switzerland, today announced an international alliance to
accelerate the clinical development of ChemGenex's lead anti-cancer therapeutic,
Ceflatonin®. Ceflatonin® is currently in a Phase 2 Clinical Trial at the M.D.
Anderson Cancer Center in Houston, Texas treating chronic myeloid leukemia (CML)
patients who are resistant to Gleevec®.
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML YAHOO! GROUPS LINKS
|
